| Literature DB >> 34664173 |
Imen Haddaoui1,2, Javier Mateo-Sagasta3.
Abstract
Little is known about the occurrence of emerging pollutants (EPs) in waters in the Middle East and North Africa (MENA) region despite the extensive use of low-quality water there. Available data dealing with the sources, occurrence and removal of EPs within the MENA region in different categories of water is collected, presented and analyzed in this literature review. According to the collected database, the occurrence and removal efficiency of EPs in the water matrix in the MENA region is available, respectively, for 13 and six countries of the 18 in total; no available data is registered for the rest. Altogether, 290 EPs have been observed in different water matrices across the MENA countries, stemming mainly from industrial effluents, agricultural practices, and discharge or reuse of treated wastewater (TWW). Pharmaceutical compounds figure among the most frequently reported compounds in wastewater, TWW, surface water, and drinking water. Nevertheless, pesticides are the most frequently detected pollutants in groundwater. Worryingly, 57 cases of EPs have been reported in different fresh and drinking waters, exceeding World Health Organization (WHO) and European Commission (EC) thresholds. Overall, pharmaceuticals, organic compounds, and pesticides are the most concerning EP groups. The review revealed the ineffectiveness of treatment processes used in the region to remove EPs. Negative removals of some EPs such as carbamazepine, erythromycin, and sulfamethoxazole were recorded, suggesting their possible accumulation or release during treatment. This underlines the need to set in place and strengthen control measures, treatment procedures, standards, and policies for such pollutants in the region.Entities:
Keywords: Emerging pollutants; Fresh water; Irrigation; MENA region; Raw wastewater; Treated wastewater
Mesh:
Substances:
Year: 2021 PMID: 34664173 PMCID: PMC8718386 DOI: 10.1007/s11356-021-16558-8
Source DB: PubMed Journal: Environ Sci Pollut Res Int ISSN: 0944-1344 Impact factor: 4.223
Sources and examples of emerging pollutants
| Human hormones | Estrone, estriol, testosterone, 17β-estradiol | ||
| Human pharmaceuticals | Carbamazepine, caffeine, naproxen, atenolol, ibuprofen, gemfibrozil, diclofenac | ||
| Illicit drugs | Cocaine, MDMA | ||
| Personal care products | Triclosan, diethyl-meta-toluamide (DEET), parabens,benzylparaben, butylparaben | ||
| Phenols | ‘Soft’ ionic surfactants | ||
| Food additives | Caffeine, sucralose, acesulfame | ||
| Veterinary pharmaceuticals | Vancomycin, sulfamethoxazole, diclofenac | ||
| Aquaculture pharmaceuticals | Octyltetracycline | ||
| Pesticides | Atrazine, triazine, simazine, hexachlorocyclohexane (HCH), gamma-hexachlorocyclohexane (γ-HCH), dichlorodiphenyltrichloroethane(DDT), dichlorodiphenyldichloroethane (DDD), dichlorodiphenyldichloroethylene (DDE), dieldrin | ||
| Animal hormones | Estradiol, estrone, estriol | ||
| Other organic compounds (that cannot be classified in other groups) | Polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), chlorinated hydrocarbons, perfluoroalkyl and polyfluoroalkyl substances (PFASs), volatile organic compounds (butylbenzene, m-xylene … ) | ||
| Plasticizers | Bisphenol A, phthalates, phthalate esters | ||
| Personal care products | Tonalide, galaxolide, DEET, benzophenone, oxybenzone, parabens,benzylparaben, butylparaben,methylparaben | ||
| Phenols | ‘Hard’ non-ionic surfactants (2,4-dinitrophenol, 2-nitrophenol, octylphenol, nonylphenol mono and diethoxylates, nonylphenol carboxylates, nonylphenolethoxycarboxylates, nonylphenolethoxylates) | ||
| Human pharmaceuticals | Carbamazepine, ibuprofen, paracetamol, atenolol, lidocaine, clarithromycin, nacetylsulfamethoxazol (NACS) | ||
Fig. 1Number of publications dealing with the monitoring of different groups of EPs (from 1976 to September 2020) in wastewater, TWW, surface water, groundwater, and drinking waters in the MENA region
Fig. 2Year-wise distribution of 89 published studies drawn from a database (from 1976 to September 2020) dealing with the monitoring of EPs in wastewater, TWW, surface water, groundwater, and drinking waters in the MENA region
Fig. 3Distribution of studies on EPs in different water matrices by country in the MENA region
Fig. 4Median values and variation in the concentration levels of the 20 most-investigated EPs in individual samples of raw wastewater in the MENA region (n= 186)
Fig. 5Median values and variation in the concentration of the 20 most-investigated EPs in individual samples of treated wastewater in the MENA region (n= 240)
Fig. 6Median values and variation in the concentration levels of 20 most-investigated EPs in individual samples of surface water in the MENA region (n= 87)
Fig. 7Median values and variation in concentration levels of 20 most-investigated EPs observed in individual samples of groundwater in the MENA region (n= 97)
The removal efficiency of selected EPs in existing wastewater treatment plants in the MENA region.
| Maximum secondary | Activated sludge | 65 | -40 to 22.5 | 55–100 | -173.7 to 30.3 | -25 | 97.6–100 | 74.6–98.8 | -31 to 45.8 |
| Tricking filter | - | 75 | - | - | 60–75 | - | |||
| Sequential biological reactor (SBR) | - | - | - | - | - | 93.5 | - | ||
| Rotating biological contactor (RBC) | 25 | -43 to 60 | - | 44–100 | 20–100 | - | - | # | |
| Aeration pond | - | - | - | - | - | - | 93.2 | - | |
| Maximum tertiary | Polishing with sand filtration and disinfection with chlorine | >99 | >86 | 26–>99 | 86.1–90.9 | - | 97.1* 94.7** | >98 | |
| Membrane bioreactor (MBR) | - | - | - | - | - | - | 98 | - | |
| Aerated lagoon | - | -78 | - | - | - | - | - | - | |
| Waste stabilization pond | - | 0–33 | - | 65–100 | 17–100 | - | - | 100 | |
| Extensive systems | Soil-aquifer treatment | - | - | - | - | - | 98–100 | 98–100 | - |
#Sulfamethoxazole was not detected in influent WWTPs but was found in the effluent in WWTPs (300 ng/L) using RBC treatment technology
*Polishing with sand filtration/**disinfecting with UV instead of chlorine/CAF, caffeine; CAR, carbamazepine; CIPRO, ciprofloxacin; DIC, diclofenac; ERY, erythromycin; E3, estriol; E1, estrone; and SMX, sulfamethoxazole
Fig. 8Box and whisker plot showing the median value and variation in caffeine concentrations in individual samples taken from different water types (n= 59) in the MENA region. (Mokh et al. 2017; Craddock et al. 2020; Moslah et al. 2017; Hassine et al. 2011; Alahmad and Alawi, 2010; Al Qarni et al. 2016; Fries et al. 2016; Alidina et al. 2014; Malchi et al. 2014)